A groundbreaking shift in Canadian drug policy has occurred, as the government announce the use of psilocybin fungi for therapeutic purposes. Until now, these substances were heavily restricted, but a growing body of research suggests they may offer benefits for mental health illnesses like depression. This development represents a key step toward